InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,474.21
(
0.87%
)
US TECH 100
18,664.40
(
0.70%
)
Dow Jones
40,320.62
(
1.17%
)
Brent Oil
81.30
(
0.69%
)
Bitcoin
64,866.44
(
-0.78%
)
Post# of 252676
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: JohnWayne post# 154121

Friday, 12/14/2012 1:30:02 PM

Friday, December 14, 2012 1:30:02 PM

Post# of 252676

So they did get a broad second-line label, but with a fair amount of fanfare around AEs and CV risks. I don't think that bodes well for use ahead of 2G TKI.



The CV risks apply to Tasigna and Sprycel as well.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up